| abstract |
An anticancer drug, its preparation and its use are disclosed, in particular for the therapy of non-resectable primary and secondary liver tumours. The invention has applications in medicine and the pharmaceutical industry. The disclosed drug is characterised in that it contains lyophilised starch particles combined with one or several cytostatic agents and dissolved in iodine-, gadolinium- or magnetite-containing contrasting agents. The preferred size of the starch particles is 40-90 νm, carboplatin constitutes an important cytostatic agent and phenyl derivatives iodinated one or several times are used as iodine-containing contrasting agents. |